C799-0201 Screening compound: 1-[(1-cyclopentyl-2-methyl-1H-1,3-benzodiazol-5-yl)sulfonyl]-N-[(3-fluorophenyl)methyl]piperidine-4-carboxamide

C799-0201 Screening compound: 1-[(1-cyclopentyl-2-methyl-1H-1,3-benzodiazol-5-yl)sulfonyl]-N-[(3-fluorophenyl)methyl]piperidine-4-carboxamide
C799-0201 Screening compound: 1-[(1-cyclopentyl-2-methyl-1H-1,3-benzodiazol-5-yl)sulfonyl]-N-[(3-fluorophenyl)methyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C799-0201
1-[(1-cyclopentyl-2-methyl-1H-1,3-benzodiazol-5-yl)sulfonyl]-N-[(3-fluorophenyl)methyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C799-0201

Molecular Formula

C26H31FN4O3S (C26 H31 FN4 O3 S)

Compound Name

1-[(1-cyclopentyl-2-methyl-1H-1,3-benzodiazol-5-yl)sulfonyl]-N-[(3-fluorophenyl)methyl]piperidine-4-carboxamide

IUPAC name

1-[(1-cyclopentyl-2-methyl-1H-13-benzodiazol-5-yl)sulfonyl]-N-[(3-fluorophenyl)methyl]piperidine-4-carboxamide

SMILES

Cc1nc(cc(cc2)S(N(CC3)CCC3C(NCc3cc(F)ccc3)=O)(=O)=O)c2n1C1CCCC1

InChI

InChI=1S/C26H31FN4O3S/c1-18-29-24-16-23(9-10-25(24)31(18)22-7-2-3-8-22)35(33,34)30-13-11-20(12-14-30)26(32)28-17-19-5-4-6-21(27)15-19/h4-6,9-10,15-16,20,22H,2-3,7-8,11-14,17H2,1H3,(H,28,32)

InChI Key

GMWPPJZUXQNCTL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14799394

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

498.62

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.622

Distribution Coefficient, logD

3.622

Water Solubility, LogSw

-3.81

Polar Surface Area

68.011

Acid Dissociation Constant (pKa)

12.56

Base Dissociation Constant (pKb)

4.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.20

C799-0201 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Immunological Library (6760 compounds)

MCL1 Targeted Library (12200 compounds)

PLpro Library (6343 compounds)

Indoleamine 2,3-dioxygenase 1 Focused Library (5816 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Immune system
Targets:
  • Others

References: we are preparing a list of scientific research reports with C799-0201 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C799-0201?
Check Price and Availability of C799-0201, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C799-0201 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C799-0201
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C799-0201
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C799-0201 available by request